Is Dr Agarwals Health Care a Good Buy After Its Q1 FY27 Results?
- September 10, 2026
- Posted by: Harsh Piplani
- Category: Uncategorized
Dr Agarwals Health Care share price around Rs 511. 10.1% below 52-week high of Rs 568. Q1 FY27 revenue Rs 620 crore, up 23.9% YoY. PAT Rs 55 crore, up 44.6%. PE 88x.
Quick Answer
Dr Agarwals Health Care’s Q1 FY27 results were strong, with revenue at Rs 620 crore and PAT climbing 45% to Rs 55 crore. The stock trades at a PE of 88x against an industry average near 68x, so some of this good news is already priced in. The Dr Agarwals Health Care share price near Rs 511 reflects that optimism, so investors weighing whether Dr Agarwals Health Care is a good buy today should focus on whether this pace of growth can be sustained rather than just this quarter’s print.
The Dr Agarwals Health Care share price has been under the spotlight this results season after the company reported its first-quarter numbers for FY27. Dr Agarwals Health Care is one of the largest eye care hospital chains in India and Southeast Asia, and its Q1 FY27 print, for the quarter ended June 30, 2026, gives investors a fresh data point to test whether the stock still deserves a place in a portfolio at current levels.
Revenue for the quarter came in at Rs 620 crore, up 23.9% year on year, while profit after tax came in at Rs 55 crore, up 44.6% from a year earlier. That combination of numbers is exactly what this article breaks down, along with what it means for the Dr Agarwals Health Care share price from here.
This piece works through the quarter’s financial highlights, the business factors behind the numbers, where the Dr Agarwals Health Care share price stands against its 52-week range and valuation multiples, and the key risks worth watching before treating this as a buy, hold or a stock to avoid for now.
Click Here – Get Free Investment Predictions
Dr Agarwals Health Care Q1 FY27 Financial Highlights
| Metric | Q1 FY27 | Q1 FY26 | YoY Change |
|---|---|---|---|
| Revenue | Rs 620 crore | Rs 501 crore | 23.9% |
| EBITDA | Rs 177 crore | Rs 141 crore | 25.2% |
| Operating Margin | 28.8% | 29.0% | NA |
| Profit Before Tax | Rs 75 crore | Rs 54 crore | 40.2% |
| Net Profit / (Loss) | Rs 55 crore | Rs 38 crore | 44.6% |
Dr Agarwals Health Care Q1 FY27 Performance Analysis
Check Dr Agarwals Health Care Fundamentals on Univest Screener
Revenue growth of 23.9% for the quarter came from steady demand across the company’s core business, keeping the topline trend intact for the eye care hospital chain sector.
The bigger story is on profitability. PAT grew 45% to Rs 55 crore, comfortably ahead of revenue growth, which points to margin expansion or a favourable base effect. This is the kind of quarter that supports the premium the Dr Agarwals Health Care share price already commands, though investors should check whether the growth is repeatable or was helped by one-off factors.
On a sequential basis, revenue moved up 7.6% sequentially from Rs 577 crore in the March 2026 quarter and net profit moved up 10.1% sequentially from Rs 50 crore in the prior quarter, giving a fuller picture of the trend behind the Dr Agarwals Health Care share price than the year on year comparison alone.
Key Business Factors in Q1 FY27
Revenue Trend
Dr Agarwals Health Care’s revenue grew 23.9% year on year this quarter, taking the quarterly base to Rs 620 crore in an eye care hospital chain business that remains sensitive to demand and pricing cycles that ultimately feed through to the Dr Agarwals Health Care share price.
Margin Movement
EBITDA rose 25.2% to Rs 177 crore, and operating margin moved to 28.8% from 29.0% a year earlier, a sign that cost control or pricing held up during the quarter.
Balance Sheet Position
Dr Agarwals Health Care’s debt-to-equity ratio stands at 0.53, a level worth monitoring given the quarter’s margin trend.
Valuation Context
The stock trades at a PE of 88.0x against an industry average of 67.5x, a premium that this quarter’s results will need to justify going forward.
Dividend Details
No interim dividend was declared alongside Dr Agarwals Health Care’s Q1 FY27 results. The stock has not paid a meaningful dividend in the trailing twelve months. Investors tracking the Dr Agarwals Health Care share price for income should watch the company’s announcements around its next annual results for any dividend decision.
Dr Agarwals Health Care Share Price Outlook for FY27
The Q1 FY27 print sets a reasonably high bar for the rest of the year. If Dr Agarwals Health Care can sustain this pace of revenue and profit growth, the current valuation gets easier to justify. The main swing factor is whether this quarter’s momentum reflects a durable trend or a favourable one-off, something the next two quarters should clarify.
For the Dr Agarwals Health Care share price to hold its current premium through FY27, the company will likely need to keep posting growth at or near this quarter’s pace, since any slowdown would put pressure on a stock priced for continued strength.
Dr Agarwals Health Care Stock Performance
Download the Univest iOS App or Univest Android App to track Dr Agarwals Health Care’s live share price and get daily stock updates.
The Dr Agarwals Health Care share price was trading around Rs 511 as results season played out in late August 2026, roughly 10.1% below its 52-week high of Rs 568 and well above its 52-week low of Rs 401. Promoter holding stood at 32.3% as of the June 2026 quarter.
The Dr Agarwals Health Care share price has room to re-rate further if the growth shown this quarter continues, though much of the good news may already be reflected in the stock near current levels. On profitability ratios, the company reports a return on equity of 6.58% and a book value of around Rs 64 per share, both useful reference points when judging whether the current price is reasonable.
Key Risks
Valuation Risk
At 88.0x earnings against an industry average of 67.5x, the stock leaves little room for disappointment if growth slows.
Leverage Risk
A debt-to-equity ratio of 0.53 means the company’s earnings are more sensitive to interest rate and refinancing conditions than a lower-debt peer.
Sector and Demand Risk
As an eye care hospital chain business, Dr Agarwals Health Care’s results remain tied to sector-specific demand, pricing and regulatory cycles that can shift from quarter to quarter and move the Dr Agarwals Health Care share price well before the next result.
Conclusion
Dr Agarwals Health Care’s Q1 FY27 results were genuinely strong, with revenue at Rs 620 crore and PAT up 45% to Rs 55 crore. That said, at a PE of 88.0x, the Dr Agarwals Health Care share price is not inexpensive, so this looks like a quality business trading at a full price rather than a bargain. Existing investors have little to worry about from this print, while new investors asking whether Dr Agarwals Health Care is a good buy should weigh the strong quarter against the valuation before adding at current levels. The Dr Agarwals Health Care share price remains the number to track heading into the next quarterly update.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).
Frequently Asked Questions on Dr Agarwals Health Care Q1 FY27 Results
What were Dr Agarwals Health Care’s Q1 FY27 results?
Ans. Dr Agarwals Health Care reported Q1 FY27 revenue of Rs 620 crore, up 23.9% year on year, and PAT of Rs 55 crore, up 44.6% year on year.
Is Dr Agarwals Health Care a good buy after its Q1 FY27 results?
Ans. Dr Agarwals Health Care’s core numbers improved this quarter, though at a PE of 88.0x the stock is not inexpensive, so this suits investors comfortable paying up for quality. Investors should form their own view based on their own risk appetite and time horizon.
What is the Dr Agarwals Health Care share price today?
Ans. The Dr Agarwals Health Care share price was trading around Rs 511 in late August 2026, about 10.1% below its 52-week high of Rs 568 and well above its 52-week low of Rs 401.
What is Dr Agarwals Health Care’s revenue and profit for Q1 FY27?
Ans. Dr Agarwals Health Care reported revenue of Rs 620 crore and a net profit of Rs 55 crore for the quarter ended June 30, 2026.
Did Dr Agarwals Health Care declare a dividend with its Q1 FY27 results?
Ans. No interim dividend was declared alongside Dr Agarwals Health Care’s Q1 FY27 results. Investors should track the company’s next annual results for any dividend announcement.
What is Dr Agarwals Health Care’s PE ratio and is it expensive?
Ans. The Dr Agarwals Health Care share price trades at a trailing PE of 88.0x, against an industry average of 67.5x. Investors should compare this with the company’s growth rate before judging value.
What are the key risks for Dr Agarwals Health Care investors right now?
Ans. At 88.0x earnings against an industry average of 67.5x, the stock leaves little room for disappointment if growth slows. As an eye care hospital chain business, Dr Agarwals Health Care’s results remain tied to sector-specific demand, pricing and regulatory cycles that can shift from quarter to quarter and move the Dr Agarwals Health Care share price well before the next result.
What is Dr Agarwals Health Care’s promoter shareholding?
Ans. Promoter holding in Dr Agarwals Health Care stood at 32.3% as of the June 2026 quarter.
